THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING
Health Answers

Can Fosamax, the osteoporosis drug, damage the jaw?

August 28, 2006

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size +

In rare cases, bisphosphonates, the class of medicines to which Fosamax belongs, have been linked to the death of jaw bone tissue. But the bisphosphonates mostly likely to cause this tissue death are the intravenous forms, such as Zometa or Aredia, which are given to cancer patients to retard the spread of tumors in the bone. (Full article: 392 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $9.95 1 month archives pass
  • $24.95 3 months archives pass
  • $74.95 1 year archives pass